AMILI  logo — AMILI is a precision gut microbiome company based in Singapo...

AMILI

AMILI is a precision gut microbiome company based in Singapore serving the region.

Founded 2019 Singapore Singapore 40 employees Venture round Total: $10.50M Health Care, Health and Wellness +1

General Information

Company Name AMILI
Founded Year 2019
Location Singapore Singapore
Employees 40
Industries Health Care, Health and Wellness, Sports
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with AMILI . To contact AMILI , visit amili.asia.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does AMILI compare?

A PDF of AMILI and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting AMILI soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About AMILI

AMILI is a precision gut microbiome company based in Singapore, serving the region. Through AMILI's proprietary analytics engine, PRIME, they develop diagnostics tests, predictive algorithms, and microbiome-modifying interventions. Their consumer health arm, BIO & ME, utilizes insights from AMILI's database and PRIME to generate Asia-centric solutions towards personalized diet, supplementation, and precision health. AMILI also houses Southeast Asia's first and only gut microbiome bank for clinical use and research. The company, founded in 2019, operates in the Health Care industry. Their most recent Venture Round investment occurred on 29 May 2023, with investment from East Ventures. For more information, visit www.amili.asia.

Business keywords: Precision Gut Microbiome, Diagnostics Tests, Predictive Algorithms, Microbiome-Modifying Interventions, Consumer Health, Personalised Diet, Supplementation, Precision Health, Microbiome Database, Faecal Microbiota Transplants, Stool Bank, Research and Development, Innovation, Probiotics

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Undisclosed 1
East Ventures
29 May 2023
Series A $10.50M 9
SEEDS Capital, TVM Capital Healthcare +7
15 Jun 2022

AMILI Alternatives & Competitors

AMILI vs
DayTwo
DayTwo United States

Precision Nutrition for Metabolic Disease

16 employees
Biotechnology, Health Care
AMILI vs
Jona
Jona United States

Discover Within

Seed
27 employees
AI, Health Care

FAQ About AMILI

AMILI is a precision gut microbiome company based in Singapore serving the region.
AMILI was founded in 2019.
AMILI is headquartered in Singapore.
AMILI operates in Health Care, Health and Wellness and Sports. Its work centres on Precision Gut Microbiome, Diagnostics Tests, Predictive Algorithms and Microbiome-Modifying Interventions.
AMILI has approximately 40 employees.
AMILI has completed 2 funding rounds, raising a total of $10.50M. The latest funding stage is Venture round.
Top alternatives and competitors to AMILI include DayTwo, Jona. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
AMILI and DayTwo are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for AMILI , https://bouncewatch.com/company/amili, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes